Ditto Biosciences is a biotechnology company dedicated to developing innovative therapies for autoimmune diseases by harnessing the unique properties of parasite biology. By leveraging artificial intelligence and evolutionary genomics, Ditto Biosciences identifies and engineers proteins from viruses, ticks, and worms into next-generation therapeutics aimed at modulating the human immune system. Key Features and Functionality: - AI-Powered Drug Discovery: Utilizes artificial intelligence to analyze and transform parasite-derived proteins into potential therapeutic agents. - Evolutionary Genomics Integration: Combines evolutionary genomics with AI to understand and leverage the properties of parasite proteins for drug development. - Targeted Autoimmune Therapies: Focuses on creating solutions to suppress inflammation and remodel tissues, offering innovative treatments for autoimmune conditions. Primary Value and Problem Solved: Ditto Biosciences addresses the significant challenge of developing effective treatments for autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. By mining the genomes of parasites that have evolved mechanisms to modulate the human immune response, Ditto Biosciences aims to translate these naturally occurring proteins into novel therapies. This approach offers a promising avenue for creating safe and effective drugs that can restore immune balance in patients suffering from autoimmune disorders.